Sipavibart - CISMeF

Preferred Label : Sipavibart;

NCIt synonyms : Anti-SARS-CoV-2 Monoclonal Antibody AZD3152;

NCIt definition : A long-acting neutralizing human monoclonal antibody derived from B-cells of convalescent patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and directed against SARS-CoV-2, that can potentially be used for passive immunization against Coronavirus disease 2019 (COVID-19). Upon administration, sipavibart neutralizes SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2.;

UNII : 977D2P9YYW;

CAS number : 2768288-97-5;

Molecule name : AZD-3152; AZD 3152;

NCI Metathesaurus CUI : CL1907351;

Details

Origin ID

C200075;

UMLS CUI

C5854470;

Currated CISMeF NLP mapping
- Sipavibart [SMS substance]
Manual BTNT mappings - CISMeF
- sipavibart [ATC Code]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients